Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF).

被引：0
|
作者：
Mendoza, Onofre Moran [1 ,2 ]
Aldaheri, Sharina [1 ,2 ]
Alyami, Sami [1 ,2 ]
Kish, Maxine [1 ]
Davison, Sean [1 ]
机构：
[1] Queens Univ, Kingston, ON, Canada
[2] Kingston Hlth Sci Ctr, Kingston, ON, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA2904
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2904
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF)
    Balestro, Elisabetta
    Turato, Graziella
    Biondini, Davide
    Pavanello, Sofia
    Fraccaro, Alessia
    Rigobello, Chiara
    Bazzan, Erica
    Campisi, Manuela
    Baraldo, Simonetta
    Cosio, Manuel
    Saetta, Marina
    Spagnolo, Paolo
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [32] Ascertainment Of Individual Risk Of Mortality For Patients With Idiopathic Pulmonary Fibrosis (IPF)
    Du Bois, R. M.
    Albera, C.
    Bradford, W. Z.
    Costabel, U.
    Kartashov, A.
    Noble, P. W.
    Raghu, G.
    Szwarcberg, J.
    Thomeer, M.
    Valeyre, D.
    Weycker, D.
    King, T. E., Jr.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [33] Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients
    Ronan, Nicola
    Khan, Kashif A.
    Subramaniam, Abirami
    McCarthy, Yvonne
    Burke, Louise
    Chelliah, A.
    Plant, Barry J.
    Henry, Michael T.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [34] Could Hepcidin Be a New Biomarker in Patients with Idiopathic Pulmonary Fibrosis (IPF)?
    Yilmaz, Gulcin
    Coban, Hikmet
    Sarioglu, Nurhan
    Erel, Fuat
    Yilmaz, Merve Akis
    Colak, Mustafa
    Senel, Merve Yumrukuz
    Hismiogullari, Adnan Adil
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (22)
  • [35] Predicting Mortality in Idiopathic Pulmonary Fibrosis (IPF) Patients Treated with Nintedanib
    Tang, W.
    Menjoge, S.
    Stowasser, S.
    Korell, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [36] Gastroesophageal reflux (GER) in idiopathic pulmonary fibrosis (IPF) patients.
    Tobin, R
    Porter, A
    Mageto, Y
    Sillery, J
    Pope, C
    Raghu, G
    GASTROENTEROLOGY, 1997, 112 (04) : A313 - A313
  • [37] Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF)
    Rodriguez Jimeno, Elena
    Pedraza Serrano, Fernando
    Oliva Ramos, Alicia
    Sanchez Munoz, Gema
    Gallo Gonzalez, Virginia
    Jimenez Garcia, Rodrigo
    Lopez De Andres, Ana
    Hernandez Barrera, Valentin
    Puente Maestu, Luis
    De Miguel Diez, Javier
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [38] Spirometric evaluation of idiopathic pulmonary fibrosis (IPF): forced or slow vital capacity?
    Rodriguez Moncalvo, Juan Jose
    Malet Ruiz, Jose
    Mastroianni, Marcelo
    Khoury, Marina
    Caro, Fabian
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [39] Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients?
    Nolan, Claire M.
    Patel, Suhani
    Barker, Ruth E.
    George, Peter M.
    Cullinan, Paul
    Maher, Toby M.
    Maddocks, Matthew M.
    Man, William D-C
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [40] EXERCISE INDUCED PULMONARY-HYPERTENSION IN PATIENTS WITH MILD IDIOPATHIC PULMONARY FIBROSIS (IPF)
    MCLEES, B
    CRYSTAL, R
    FULMER, J
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1978, 117 (04): : 371 - 371
12345